Recruiting PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT02275286

Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients (TRASTS)

Phase I-II Prospective Trial, Multicenter, Open Label, Exploring the Combination of Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients

Sponsor: Centre Leon Berard

Conditions Leiomyosarcoma Liposarcoma Liposarcoma, Myxoid Pleomorphic Liposarcoma Sarcoma, Soft Tissue

Interventions Radiotherapy Trabectedin

Updated 12 times since 2017 Last updated: May 29, 2023 Started: Nov 30, 2014 Primary completion: Jun 30, 2028 Completion: Jun 30, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02275286, this PHASE1/PHASE2 trial focuses on Leiomyosarcoma and Liposarcoma and remains actively recruiting participants. Sponsored by Centre Leon Berard, it has been updated 12 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

12 versions recorded

Sep 2025 — Present [monthly]

Recruiting PHASE1/PHASE2
Sep 2024 — Sep 2025 [monthly]

Recruiting PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jun 2023 — Jul 2024 [monthly]

Recruiting PHASE1_PHASE2
Jul 2022 — Jun 2023 [monthly]

Recruiting PHASE1_PHASE2

Status: Unknown Status → Recruiting

▶ Show 7 earlier versions

May 2022 — Jul 2022 [monthly]

Unknown Status PHASE1_PHASE2

Status: Recruiting → Unknown Status
Jan 2021 — May 2022 [monthly]

Recruiting PHASE1_PHASE2
May 2020 — Jan 2021 [monthly]

Recruiting PHASE1_PHASE2
Jan 2020 — May 2020 [monthly]

Recruiting PHASE1_PHASE2

Status: Unknown Status → Recruiting
Mar 2019 — Jan 2020 [monthly]

Unknown Status PHASE1_PHASE2

Status: Recruiting → Unknown Status
Jun 2018 — Mar 2019 [monthly]

Recruiting PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE1_PHASE2

First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Leon Berard
Grupo Espanol de Investigacion en Sarcomas
Italian Sarcoma Group

Data source: Grupo Espanol de Investigacion en Sarcomas

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aviano, Italy , Barcelona, Spain , Bologna, Italy , Bordeaux, France , Candiolo, Italy , Lyon, France , Madrid, Spain , Milan, Italy , Palma de Mallorca, Spain , Rozzano, Italy and 3 more locations